In LPS challenge, PAI-1 inhibition reduced mortality by reducing hypercoagulation, whereas, in a pneumonia model, PAI-1 deficiency attenuated neutrophil responsiveness in the lungs and increased mortality [52,53]. This evidence concerns the gene SERPINE1 and thrombophilia.